Kassim Rahawi, PharmD, Sanofi, Cambridge, USA

Articles by Kassim Rahawi, PharmD, Sanofi, Cambridge, USA

OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?

ByApril W. Armstrong, MD, MPH, Professor and Chief of Dermatology​, University of California, Los Angeles​,Kassim Rahawi, PharmD, Sanofi, Cambridge, USA,Wendell Valdecantos, MD, Sanofi, Cambridge, USA,Stella Kyaw-Soe, PharmD, MBA, Sanofi, Cambridge, USA

Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.

Latest Updated Articles